Cost Curve News - News - https://www.costcurvenews.com/blog/page/10/

The White House View on Pharm-to-Table: ‘It’s Not the Solution in Itself’

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

Three New Drugs, Three Prices, Three Disclosure Approaches

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

A Big Study Found that Semaglutide Users Saw Increased Health Spending. Should We Be Surprised?

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

How MFN Raises the Possibility of a ‘Worst of Both Worlds’ Approach to International Drug Pricing

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

Boehringer Ingelheim’s Appeal to Overturn the IRA on Constitutional Grounds is Dismissed

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

Action On IRA Lawsuits: Appeals Court Rejects the U.S. Chamber Effort on Technical Grounds

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

Pharm-to-Table Commentary on Earnings Calls: So Hot Right Now

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

A Skyrocketing Number of Big City Hospitals Are Qualifying as ‘Administratively Rural’

INFLECTION POINT/ Health Affairs Analysis Shows That Urban Hospitals Are Increasingly Able to Grab Benefits Intended for Rural Facilities All hospitals are not alike. Some are big. Some are small.

5 months ago

Keep Reading

Cost Curve News

A Skyrocketing Number of Big City Hospitals Are Qualifying as ‘Administratively Rural’

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

Cost Curve News

What the Heck Was STAT Driving At With Its Ham-Handed Attempted Takedown of Transparency Reports?

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

Keep Reading

The White House View on Pharm-to-Table: ‘It’s Not the Solution in Itself’

Three New Drugs, Three Prices, Three Disclosure Approaches

A Big Study Found that Semaglutide Users Saw Increased Health Spending. Should We Be Surprised?

How MFN Raises the Possibility of a ‘Worst of Both Worlds’ Approach to International Drug Pricing

Boehringer Ingelheim’s Appeal to Overturn the IRA on Constitutional Grounds is Dismissed

Action On IRA Lawsuits: Appeals Court Rejects the U.S. Chamber Effort on Technical Grounds

Pharm-to-Table Commentary on Earnings Calls: So Hot Right Now

A Skyrocketing Number of Big City Hospitals Are Qualifying as ‘Administratively Rural’

A Skyrocketing Number of Big City Hospitals Are Qualifying as ‘Administratively Rural’

What the Heck Was STAT Driving At With Its Ham-Handed Attempted Takedown of Transparency Reports?

Latest Posts

J&J Becomes Company No. 15 to Make a Deal with the White House, Though Details Remain Sparse

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

Empty Offices, Full Coffers: A Journalistic Expose Examines How PBMs Use Group Purchasing Organizations to Profit

The Most Interesting Drug Pricing News of the Year Is Flying Under the Radar

We’re Back at It. Here Are the Four Key Holiday Storylines to Get You Caught Up.

Popular

J&J Becomes Company No. 15 to Make a Deal with the White House, Though Details Remain Sparse

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

Empty Offices, Full Coffers: A Journalistic Expose Examines How PBMs Use Group Purchasing Organizations to Profit

The Most Interesting Drug Pricing News of the Year Is Flying Under the Radar

We’re Back at It. Here Are the Four Key Holiday Storylines to Get You Caught Up.

Happy Festivus! Cost Curve Readers Have Some Grievances They’d Like to Air.

Latest News

J&J Becomes Company No. 15 to Make a Deal with the White House, Though Details Remain Sparse

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

Subcribe To Newsletter